HCA Healthcare

Scholarly Commons
Endocrinology

Research & Publications

4-15-2021

Pheochromocytoma Presenting as Testicular Pain: An Unusual
Case Report
Jinal K. Patel
HCA Healthcare, jinal.patel@hcahealthcare.com

Varun Reddy
HCA Healthcare, varun.reddy@hcahealthcare.com

Gauthier L. Stepman
HCA Healthcare, gauthier.stepman@hcahealthcare.com

Debra Angelo
HCA Healthcare, debra.angelo@hcahealthcare.com

Johnathan Frunzi
HCA Healthcare, johnathan.frunzi2@hcahealthcare.com

Follow this and additional works at: https://scholarlycommons.hcahealthcare.com/endocrinology
Part of the Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism
Commons, Neoplasms Commons, and the Surgical Procedures, Operative Commons

Recommended Citation
Patel JK, Reddy V, Stepman G, Angelo D, Frunzi J. Pheochromocytoma Presenting as Testicular Pain: An
Unusual Case Reports in Endocrinology. 2021;2021():6699409. https://doi.org/10.1155/2021/6699409

This Case Report is brought to you for free and open access by the Research & Publications at Scholarly
Commons. It has been accepted for inclusion in Endocrinology by an authorized administrator of Scholarly
Commons.

Hindawi
Case Reports in Endocrinology
Volume 2021, Article ID 6699409, 4 pages
https://doi.org/10.1155/2021/6699409

Case Report
Pheochromocytoma Presenting as Testicular Pain: An Unusual
Case Report
Jinal K. Patel , Varun Reddy, Gauthier Stepman, Debra Angelo, and Johnathan Frunzi
Department of Internal Medicine, HCA Healthcare/USF Morsani College of Medicine GME: Medical Center of Trinity, Trinity,
FL, USA
Correspondence should be addressed to Jinal K. Patel; jinal.patel@hcahealthcare.com
Received 18 December 2020; Revised 7 March 2021; Accepted 29 March 2021; Published 15 April 2021
Academic Editor: Osamu Isozaki
Copyright © 2021 Jinal K. Patel et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pheochromocytoma (PCC) is a rare catecholamine-secreting tumor that arises from chromaﬃn cells of the adrenal medulla which
are derived from the neural crest. This report illustrates a 51-year-old Caucasian male with a history of hypertension diagnosed
two years ago who presented to the hospital due to acute onset of right testicular pain of 3-day duration. Laboratory results and
imaging revealed a presumptive diagnosis of PCC. The patient had undergone robot-assisted laparoscopic right adrenalectomy 14
days after being diagnosed with PCC due to perioperative management with phenoxybenzamine. The ﬁnal pathology report
revealed a PCC. At follow-up two weeks after discharge, the patient reported complete resolution of his testicular pain.

1. Introduction
Pheochromocytoma (PCC) is a rare catecholamine-secreting tumor that arises from chromaﬃn cells of the adrenal
medulla [1–4]. Histologically, chromaﬃn cells are derived
from the neural crest during development [1–4]. In 2017, the
World Health Organization (WHO) classiﬁed PCC as an
adrenal tumor and extraadrenal tumor as paraganglioma;
since both types of tumor cannot be diﬀerentiated on histological ﬁndings [1–4]. The incidence of PCC and paraganglioma ranges between 2 and 8 per million, whereas the
incidence of PCC is approximately 500–1600 cases per year
[5]. PCC may occur at any age; however, it is more commonly seen in the 3rd to 5th decade of life [3]. Typically,
patients present with a triad of severe headache, sweating,
and palpitations which occur in waves as a result of excess
hormone release [1–3]. Furthermore, half of the patients can
have paroxysmal hypertension. Less common symptoms
include ﬂushing, tremor, chest pain, weight loss, constipation, diarrhea, and warmth or heat intolerance [2]. The
diagnosis of PCC is a combination of urine and serum
analysis showing excess catecholamines and localization of
the tumor by computerized tomography (CT) and magnetic
resonance imaging (MRI) [1–4, 6]. Here, we present a case of

a 51-year-old Caucasian male with PCC presenting as testicular pain.

2. Case Presentation
A 51-year-old Caucasian male with a past medical history of
hypertension (diagnosed two years ago, treated with lisinopril 10 mg daily), nephrolithiasis, presented to the hospital
with a 3-day complaint of right testicular pain. The pain
radiated to the right ﬂank, was intermittent, sharp, 5/10 in
severity, aggravated with movement, and alleviated with rest.
The pain in the scrotum had not improved, which caused
him to present to the emergency department. He denied
having hypertensive episodes, headaches, sweating, ﬂushing,
and palpitations.
An initial evaluation in the emergency department
revealed the following vitals: temperature of 98.6 F, heart
rate of 81 beats per minute, blood pressure (BP) of 137/
96 mmHg, and oxygen saturation of 97% on room air. Initial
laboratory results revealed mild leukocytosis with a white
blood cell (WBC) count of 12,900 cells/mL. Due to the
patient having acute scrotal pain and elevated WBC count,
testicular etiologies such as testicular torsion, epididymitis,
varicocele, hydrocele, or chronic testicular pain were ruled
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out with a thorough physical examination and testicular
ultrasound (US). A CT of the abdomen and pelvis without
contrast revealed a large right suprarenal mass. A follow-up
CT abdomen with adrenal protocol revealed a 5.1 cm enhancing right adrenal mass, which was further detailed with
an MRI with contrast (Figure 1). With ﬁndings of an adrenal
gland mass on imaging, urine and serum analyses (Tables 1
and 2) were obtained, which revealed elevated catecholamines consistent with possible PCC. The patient was discharged home as he required perioperative blood pressure
management with phenoxybenzamine. The patient was
brought back to the hospital 14 days later for transperitoneal
robot-assisted laparoscopic right adrenalectomy due to
having multiple back surgeries. He was transferred to the
intensive care unit (ICU) postoperatively for close monitoring of hemodynamics. The ﬁnal pathology report revealed
a PCC, 6.2 cm in size, with no evidence of necrosis, capsular
invasion, or extension into periadrenal adipose tissue. The
patient was discharged home on postoperative day three and
to follow-up with hematology and oncology for surveillance
and possible adjuvant chemotherapy. At follow-up two
weeks after discharge, the patient reported complete resolution of his testicular pain.

3. Discussion
Testicular pain with acute onset warrants emergent evaluation with a thorough history and physical examination as
well as urinalysis and imaging [7, 8]. For example, testicular
torsion is a medical emergency, which presents as a highriding testicle, which is conﬁrmed with a scrotal US and can
result in loss of testes if there is a delay of care [7–9]. In our
patient, we were able to rule out potential medical emergencies with examination, urinalysis, and imaging as stated
above. While less common, extrascrotal etiologies can cause
testicular pain due to common nerve root pathways (T10T12, L1-L2, and S2–S4) [10]. Thus, pathologies such as
ureteral calculi, back pain, aortic aneurysm, intervertebral
disc prolapse, hernias, and other intrabdominal pathologies
that share common nerve pathways may present as acute
testicular pain [10], which was the case of our patient.
Our case is unique, as there have not been reported cases
previously of PCC presenting as testicular pain. On the other
hand, Cheungpasitporn et al. reported a case of adrenocortical carcinoma that presented as varicocele and renal
vein thrombosis [11].
The majority of PCC are initially discovered as incidentalomas, while others are suspected in patients presenting with the typical symptoms as mentioned in the
introduction or secondary cause of hypertension [12]. Our
patient likely did not have the typical presentation of PCC as
his hypertension was treated with lisinopril for the past 2
years, which likely masked his symptoms of catecholamine
excess. In our case, the patient did not have evidence of acute
testicular etiology as stated above, which warranted further
investigation with a CT of the abdomen and pelvis as the
patient had a history of renal calculi. There was no evidence
of nephrolithiasis; however, there was an incidental ﬁnding
of an adrenal mass. When an adrenal mass is found
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Figure 1: T2-Weighted MRI of the abdomen: slight increased T2
signal and heterogeneous enhancement of the right adrenal gland
(arrows).

Table 1: Urine analysis.
Urine analysis
Epinephrine
Epinephrine in 24 hours
Norepinephrine
Norepinephrine in 24 hours
Metanephrine
Metanephrine in 24 hours
Normetanephrine
Normetanephrine in 24 hours
Dopamine
Dopamine in 24 hours

Results
24 ug/L
58
128 ug/L
307
562 ug/L
1345
4520 ug/L
10848
112 ug/L
269

Reference range
Undeﬁned
0–20 ug/24 hr
Undeﬁned
0–135 ug/24 hr
Undeﬁned
45–290 ug/24 hr
Undeﬁned
82–500 ug/24 hr
Undeﬁned
0–510 ug/24 hr

Table 2: Serum analysis.
Serum analysis
Carcinoembryonic antigen
Renin activity
Aldosterone
DHEA sulfate
AM cortisol
PM: 3.09–16.66 mcg/dL
ACTH
Plasma metanephrine
Plasma normetanephrine

Results
2.1
3.010
1.1
151.0
2.29

Reference range
0.0–0.5 ng/mL
0.167–5.380 ng/mL/hr
0.0–30.0 ng/dL
80.0–560.0 ng/dL
AM: 4.30–22.40 mcg/dL

8.9
510
5648

7.2–63.3 pg/mL
0–62 pg/mL
0–145 pg/mL

DHEA: dihydroepiandrosterone, ACTH: adrenocorticotropic hormone.

incidentally, the next step in management is to determine if
it is malignant or functioning, which can be determined with
laboratory tests and imaging studies [1–4]. PCC has increased attenuation on unenhanced CT scan revealing
greater than 20 Hounsﬁeld units (HU), with a delay in
contrast medium washout [13, 14]. Our patient’s CT scan
measured 64 HU prior to contrast administration, which
enhanced heterogeneously following contrast injection with
delay in contrast medium washout. Also, PCC shows high
signal intensity on T2-weighted MRI [13, 14]. Our patient’s
MRI demonstrated a slightly increased T2 signal and heterogeneous enhancement. Due to the imaging ﬁndings, PCC
was higher on the diﬀerential and requires further investigation with biochemical assay [1–6, 15]. A 24-hour urinary
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metanephrine and plasma metanephrines were positive for
excess catecholamines (Tables 1 and 2), further supporting
the presumptive diagnosis of PCC. We later obtained a CT of
the chest and MRI of the brain for staging, which was
negative for metastatic disease. Once the diagnosis of PCC is
conﬁrmed, the next step in management is surgical resection
[2, 16]. Our patient had undergone robot-assisted laparoscopic right adrenalectomy.
While surgical resection of the tumor is usually deﬁnitive, it is associated with high mortality risk if not
managed medically ﬁrst [15]. Physical manipulation of the
adrenal gland during surgery can cause a sudden release of
catecholamines and cause intraoperative hypertensive
emergency [15–17]. Thus, in the perioperative period, it is
important to start patients on adrenergic blocking agents
10–14 days prior to surgery to decrease intraoperative
hypertensive crisis [15–17]. Initial treatment consists of
alpha-blockade with medications like phenoxybenzamine
[17]. Our patient in the perioperative period was treated
with phenoxybenzamine beginning 14 days prior to surgery. Alpha-blockage prevents peripheral vascular constriction and subsequently causes reﬂexive tachycardia.
Beta-blockers are initially avoided, as blocking this initial
reﬂex can cause dangerous hypertension due to unopposed
alpha blockade. Once an adequate alpha-blockade has been
achieved, which can be indicated by postural hypotension,
a beta-blocker can be added. Our patient did report postural hypotension but was not treated with a beta-blocker.
On the other hand, increased salt and ﬂuid intake can be
recommended to expand the intravascular volume and
maintain BP preoperatively, which was done in our patient.
After appropriate perioperative management is achieved,
the ﬁnal step in management is adrenalectomy. A patient
may have the option of undergoing an open approach,
laparoscopic or robotic-assisted laparoscopy adrenalectomy [16, 18, 19]. Comparing the diﬀerent surgical approaches, robotic-assisted approach has been shown to
decrease blood loss and have shorter hospital course when
compared to open and laparoscopic approach [19]. In
robotic-assisted adrenalectomy, patients may undergo
transperitoneal or retroperitoneal laparoscopic adrenalectomy [16, 18]. Ultimately, our patient had undergone
transperitoneal robot-assisted laparoscopic right adrenalectomy as he had multiple previous back surgeries. After
surgical removal of the adrenal gland, patients should be
monitored closely in the ICU due to potential complications of abrupt decline in catecholamine levels after tumor
resection [20]. Finally, patients should be followed up with
an MRI for recurrence for at least 10 years even after
complete resection [6].

4. Conclusion
Physicians should be aware that testicular tenderness
needs further evaluation if a thorough history and physical
exam do not reveal a cause. Furthermore, the combination
of testicular pain and hypertension should raise suspicion
for PCC, even in the absence of the typical symptoms for
PCC.
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